Clinical trial
Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung…
NCT00104767 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00104767 |
|---|---|
| Title | Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer |
| Official title | A Phase I Trial to Evaluate Cyclooxygenase 2 Inhibitor-Mediated Modulation of T Regulatory Cells in Advanced Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | celecoxib |
| Enrollment | 7 |
| Start date | Jan 1, 2009 |
| Primary completion | Oct 1, 2014 |
| Completion | Oct 1, 2015 |
| First posted | Mar 4, 2005 |
| Last update posted | Oct 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: